Anca Prica
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 23
-
- Lymphoma Diagnosis and Treatment 59
- Hematology top 10%
- Multiple Myeloma Research and Treatments 23
- Oncology top 10%
- Viral-associated cancers and disorders 16
- CAR-T cell therapy research 9
-
- CNS Lymphoma Diagnosis and Treatment 13
-
- Protein Degradation and Inhibitors 11
-
- Economic and Financial Impacts of Cancer 10
- Co-authors
- Matthew C. CheungKelvin ChanRena BucksteinMichael CrumpAbi VijenthiraMichelle SholzbergJohn KuruvillaVishal Kukreti
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Anca Prica
104 papers receiving 594 citations
Peers
Comparison fields: 5 of 76
- Genetics 147
- Pathology and Forensic Medicine 234
- Hematology 141
- Oncology 238
- Geriatrics and Gerontology 16
Countries citing papers authored by Anca Prica
This map shows the geographic impact of Anca Prica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anca Prica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anca Prica more than expected).
Fields of papers citing papers by Anca Prica
This network shows the impact of papers produced by Anca Prica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anca Prica. The network helps show where Anca Prica may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anca Prica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 3 | |
| 15 | 2021 | 44 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2017 | 1 | |
| 20 | 2016 | 12 |
About Anca Prica
Anca Prica is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 130 papers that have together received 609 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (59 papers), Chronic Lymphocytic Leukemia Research (23 papers), Multiple Myeloma Research and Treatments (23 papers), Viral-associated cancers and disorders (16 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Protein Degradation and Inhibitors (11 papers), Economic and Financial Impacts of Cancer (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Genetics (147 citations), Pathology and Forensic Medicine (234 citations) and Hematology (141 citations). Anca Prica has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Matthew C. Cheung, Kelvin Chan, Rena Buckstein, Michael Crump, Abi Vijenthira, Michelle Sholzberg, John Kuruvilla, Vishal Kukreti, Donna Reece and Suzanne Trudel.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.